Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation.
作者信息
Mayeur Claire, Kolodziej Starsha A, Wang Amy, Xu Xin, Lee Arthur, Yu Paul B, Shen John, Bloch Kenneth D, Bloch Donald B
机构信息
Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
出版信息
Haematologica. 2015 Feb;100(2):e68-71. doi: 10.3324/haematol.2014.111484. Epub 2014 Oct 17.
Abstract
摘要
相似文献
1
Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation.口服骨形态发生蛋白I型受体抑制剂可预防炎症性贫血的发生。
Haematologica. 2015 Feb;100(2):e68-71. doi: 10.3324/haematol.2014.111484. Epub 2014 Oct 17.
2
Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.抑制骨形态发生蛋白信号可减轻炎症相关贫血。
Blood. 2011 May 5;117(18):4915-23. doi: 10.1182/blood-2010-10-313064. Epub 2011 Mar 10.
3
A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.一种铁调素降低剂可动员铁用于红细胞生成，在腺嘌呤诱导的大鼠贫血肾病模型中。
Nephrol Dial Transplant. 2013 Jul;28(7):1733-43. doi: 10.1093/ndt/gfs584. Epub 2013 Jan 22.
4
Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.血管抑肽-1 的表达受肿瘤相关巨噬细胞和胰腺癌细胞间转化生长因子-β/骨形态发生蛋白信号通路的调控。
J Interferon Cytokine Res. 2013 Aug;33(8):428-33. doi: 10.1089/jir.2012.0046. Epub 2013 May 7.
5
The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease.骨形态发生蛋白-铁调素轴作为炎症性肠病的治疗靶点。
Inflamm Bowel Dis. 2012 Jan;18(1):112-9. doi: 10.1002/ibd.21675. Epub 2011 Feb 23.
6
Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B.炎症引起的铁调素上调独立于激活素B介导的Smad1/5/8信号传导。
Blood. 2017 Jan 26;129(4):533-536. doi: 10.1182/blood-2016-10-748541. Epub 2016 Nov 30.
7
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism.多索茶碱抑制胚胎发育和铁代谢所需的骨形态发生蛋白信号。
Nat Chem Biol. 2008 Jan;4(1):33-41. doi: 10.1038/nchembio.2007.54. Epub 2007 Nov 18.
8
Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.抑制骨形态发生蛋白信号可减少血管钙化和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):613-22. doi: 10.1161/ATVBAHA.111.242594. Epub 2012 Jan 5.
9
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats.药物抑制铁调素表达可逆转大鼠慢性炎症性贫血。
Blood. 2011 Nov 3;118(18):4977-84. doi: 10.1182/blood-2011-03-345066. Epub 2011 Jul 5.
10
Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.TM6PRSS6 通过下调 BMP/Smad 信号通路来维持全身铁稳态。
Blood. 2010 May 6;115(18):3817-26. doi: 10.1182/blood-2009-05-224808. Epub 2010 Mar 3.
引用本文的文献
1
Anemia of Inflammation.炎症性贫血
Adv Exp Med Biol. 2025;1480:179-195. doi: 10.1007/978-3-031-92033-2_13.
2
Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology.采用 DNA 编码化学技术发现高效的、ALK2/ALK1 选择性的激酶抑制剂。
Proc Natl Acad Sci U S A. 2024 Nov 19;121(47):e2413108121. doi: 10.1073/pnas.2413108121. Epub 2024 Nov 14.
3
Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis-Mechanistic Insights into Anemia of Inflammation and Its Treatment.铁稳态的生理学和炎症驱动病理生理学-炎症性贫血及其治疗的机制见解。
Nutrients. 2021 Oct 22;13(11):3732. doi: 10.3390/nu13113732.
4
Bioactive Lipid O-cyclic phytosphingosine-1-phosphate Promotes Differentiation of Human Embryonic Stem Cells into Cardiomyocytes via ALK3/BMPR Signaling.生物活性脂质 O-环状神经酰胺-1-磷酸通过 ALK3/BMPR 信号促进人胚胎干细胞向心肌细胞分化。
Int J Mol Sci. 2021 Jun 29;22(13):7015. doi: 10.3390/ijms22137015.
5
Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.解决铁稳态机制和缺铁性疾病。
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI148671.
6
Improving Right Ventricular Function by Increasing BMP Signaling with FK506.通过增加 FK506 的 BMP 信号来改善右心室功能。
Am J Respir Cell Mol Biol. 2021 Sep;65(3):272-287. doi: 10.1165/rcmb.2020-0528OC.
7
Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development.红系祖细胞发育失调诱导的肿瘤免疫逃逸
Cancers (Basel). 2021 Feb 19;13(4):870. doi: 10.3390/cancers13040870.
8
Regulation of Iron Homeostasis and Related Diseases.铁稳态调节与相关疾病。
Mediators Inflamm. 2020 May 2;2020:6062094. doi: 10.1155/2020/6062094. eCollection 2020.
9
A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia.类风湿关节炎合并慢性病贫血和缺铁性贫血患者中白细胞介素6、炎症标志物、铁蛋白及血液学指标的比较研究
Anemia. 2019 Apr 1;2019:3457347. doi: 10.1155/2019/3457347. eCollection 2019.
10
Hepcidin Therapeutics.铁调素疗法公司。
Pharmaceuticals (Basel). 2018 Nov 21;11(4):127. doi: 10.3390/ph11040127.
本文引用的文献
1
Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.铁调素作为大鼠慢性病贫血促红细胞生成素治疗的预测因子和治疗靶点
Haematologica. 2014 Sep;99(9):1516-24. doi: 10.3324/haematol.2013.099481. Epub 2014 Jun 3.
2
Manipulation of the hepcidin pathway for therapeutic purposes.针对治疗目的对铁调素途径的操控。
Haematologica. 2013 Nov;98(11):1667-76. doi: 10.3324/haematol.2013.084624.
3
Systemic iron homeostasis.系统性铁稳态。
Physiol Rev. 2013 Oct;93(4):1721-41. doi: 10.1152/physrev.00008.2013.
4
Peginesatide for anemia in chronic kidney disease.聚乙二醇化促红细胞生成素用于慢性肾脏病贫血的治疗
N Engl J Med. 2013 Apr 18;368(16):1553-4. doi: 10.1056/NEJMc1302314.
5
Treatment of anemia with darbepoetin alfa in systolic heart failure.达贝泊汀α治疗收缩性心力衰竭伴贫血。
N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10.
6
A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.一种铁调素降低剂可动员铁用于红细胞生成，在腺嘌呤诱导的大鼠贫血肾病模型中。
Nephrol Dial Transplant. 2013 Jul;28(7):1733-43. doi: 10.1093/ndt/gfs584. Epub 2013 Jan 22.
7
Late stage erythroid precursor production is impaired in mice with chronic inflammation.慢性炎症小鼠的晚期红系前体细胞生成受损。
Haematologica. 2012 Nov;97(11):1648-56. doi: 10.3324/haematol.2011.053397. Epub 2012 May 11.
8
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats.药物抑制铁调素表达可逆转大鼠慢性炎症性贫血。
Blood. 2011 Nov 3;118(18):4977-84. doi: 10.1182/blood-2011-03-345066. Epub 2011 Jul 5.
9
Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.抑制骨形态发生蛋白信号可减轻炎症相关贫血。
Blood. 2011 May 5;117(18):4915-23. doi: 10.1182/blood-2010-10-313064. Epub 2011 Mar 10.
10
Q: Is iron therapy for anemia harmful in the setting of infection?问：在感染情况下，用于治疗贫血的铁剂疗法有害吗？
Cleve Clin J Med. 2011 Mar;78(3):168-70. doi: 10.3949/ccjm.78a.10156.
Zotero 插件